NASDAQ: ADGI - Adagio Therapeutics, Inc.

Yield per half year: 0%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Adagio Therapeutics, Inc.


About Adagio Therapeutics, Inc.

Adagio Therapeutics, Inc., биофармацевтическая компания, работающая на клинической стадии, занимается открытием, разработкой и коммерциализацией растворов на основе антител для лечения инфекционных заболеваний в США. Его основным кандидатом в продукте является ADG20, нейтрализующее антитело, которое проходит фазу II / III клинических испытаний для лечения и профилактики коронавирусной болезни. Компания заключила соглашение о сотрудничестве с Adimab, LLC в области обнаружения и оптимизации патентованных антител. Adagio Therapeutics, Inc.

more details
была зарегистрирована в 2020 году и базируется в Уолтеме, Массачусетс.

IPO date 2021-08-06
ISIN US00534A1025
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://adagiotx.com
Цена ао 3.48
Change price per day: 0% (3.48)
Change price per week: 0% (3.48)
Change price per month: 0% (3.48)
Change price per 3 month: 0% (3.48)
Change price per half year: 0% (3.48)
Change price per year: 0% (3.48)
Change price per 3 year: -12.12% (3.96)
Change price per 5 year: 0% (3.48)
Change price per 10 year: 0% (3.48)
Change price per year to date: 0% (3.48)

Underestimation

Title Value Grade
P/S 149039789.22 1
P/BV 0.99 9
P/E 0 0
EV/EBITDA 0.27 10
Total: 5

Efficiency

Title Value Grade
ROA, % -64.67 0
ROE, % -72 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0077 10
Total: 9.2

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % -0.1331 0
Yield EPS, % 113.03 10
Total: 3.8

ETF Share, % Profitability for 1 year, % Dividends, %
ProShares UltraPro Russell2000 0.00206 89.82 1.47873
Schwab U.S. Small-Cap ETF 0.00166 17.47 1.51433
ProShares Hedge Replication ETF 0.00057 5.92 1.47892
Schwab U.S. Broad Market ETF 0.00012 24.86 1.43354
Vanguard Russell 2000 ETF 0 17.16 1.48801
Vanguard Russell 3000 ETF 0 31.87 1.43817



Head Job title Payment Year of birth
Dr. Rebecca Dabora Ph.D. Chief Technology & Manufacturing Officer N/A 1960 (65 years)
Mr. David Hering M.B.A. CEO & Director 453.76k 1976 (49 years)
Ms. Laura Walker Ph.D. Co-Founder & Chief Scientific Officer N/A 1985 (40 years)
Ms. Jane Pritchett V. Henderson CFO, Chief Bus. Officer & Treasurer N/A 1966 (59 years)
Ms. Jill Andersen J.D. Chief Legal Officer & Corp. Sec. 580.12k 1973 (52 years)
Dr. Elham Hershberger Pharm.D. Chief Devel. Officer N/A 1968 (57 years)
Mr. Eric W. Kimble M.B.A. Chief Commercial Officer N/A 1968 (57 years)
Mr. Ed Campanaro Sr. VP of Clinical Operations N/A

Address: United States, Waltham. MA, 303 Wyman Street - open in Google maps, open in Yandex maps
Website: https://adagiotx.com